Madison Avenue Partners, LP - Jun 30, 2025 SCHEDULE 13G/A Report for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Filing Manager
Madison Avenue Partners, LP
Reporting Manager
Madison Avenue Partners LP
Security
Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock")
Symbol
SAGE
Shares outstanding
62.7M shares
Disclosed Ownership
6.08M shares
Ownership
9.7%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 09:22 AM
Date of event
Jun 30, 2025
Previous filing
Apr 1, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue Partners LP 9.7% 6.08M 0 6.08M s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
Madison Avenue International LP 9.7% 6.08M 0 6.08M /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
EMAI Management, LLC 9.7% 6.08M 0 6.08M /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 9.7% 6.08M 0 6.08M /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 9.7% 6.08M 0 6.08M /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 9.7% 6.08M 0 6.08M Eli Samaha ELI SAMAHA